References
- Bonneville M, O'Brien RL, Born WK (2010) Gammadelta T cell effector functions: a blend of innate programming and acquired plasticity. Nat Rev Immunol, 10, 467-78. https://doi.org/10.1038/nri2781
- Born WK, Reardon CL, O'Brien RL (2006) The function of gammadelta T cells in innate immunity. Curr Opin Immunol, 18, 31-8. https://doi.org/10.1016/j.coi.2005.11.007
- Braza MS, Caraux A, Rousset T et al (2010) gammadelta T lymphocytes count is normal and expandable in peripheral blood of patients with follicular lymphoma, whereas it is decreased in tumor lymph nodes compared with inflammatory lymph nodes. J Immunol, 184, 134-40. https://doi.org/10.4049/jimmunol.0901980
- Braza MS, Klein B, Fiol G et al (2011) gammadelta T-cell killing of primary follicular lymphoma cells is dramatically potentiated by GA101, a type II glycoengineered anti-CD20 monoclonal antibody. Haematologica, 96, 400-7. https://doi.org/10.3324/haematol.2010.029520
- Caccamo N, Meraviglia S, Ferlazzo V et al (2005) Differential requirements for antigen or homeostatic cytokines for proliferation and differentiation of human Vgamma9Vdelta2 naive, memory and effector T cell subsets. Eur J Immunol, 35, 1764-72. https://doi.org/10.1002/eji.200525983
- Cai XY, Gao Q, Qiu SJ et al (2006) Dendritic cell infiltration and prognosis of human hepatocellular carcinoma. J Cancer Res Clin Oncol, 132, 293-301. https://doi.org/10.1007/s00432-006-0075-y
- Dunn GP, Bruce AT, Ikeda H et al (2002) Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol, 3, 991-8. https://doi.org/10.1038/ni1102-991
- El-Serag HB, Rudolph KL (2007) Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology, 132, 2557-76. https://doi.org/10.1053/j.gastro.2007.04.061
- Galon J, Costes A, Sanchez-Cabo F et al (2006) Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science, 313, 1960-4. https://doi.org/10.1126/science.1129139
- Gao B, Jeong WI, Tian Z (2008) Liver: An organ with predominant innate immunity. Hepatology, 47, 729-36.
- Gao Q, Qiu SJ, Fan J et al (2007) Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. J Clin Oncol, 25, 2586-93. https://doi.org/10.1200/JCO.2006.09.4565
- Gao Q, Wang XY, Qiu SJ et al (2009) Overexpression of PDL1 significantly associates with tumor aggressiveness and postoperative recurrence in human hepatocellular carcinoma. Clin Cancer Res, 15, 971-9. https://doi.org/10.1158/1078-0432.CCR-08-1608
- Gao Q, Zhou J, Wang XY et al (2012) Infiltrating memory/senescent T cell ratio predicts extrahepatic metastasis of hepatocellular carcinoma. Ann Surg Oncol, 19, 455-66.
- Guo L, Kuroda N, Toi M et al (2001) Increased expression of platelet-derived endothelial cell growth factor in human hepatocellular carcinomas correlated with high Edmondson grades and portal vein tumor thrombosis. Oncol Rep, 8, 871-6.
- Ikai I, Arii S, Kojiro M et al (2004) Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey. Cancer, 101, 796-802. https://doi.org/10.1002/cncr.20426
- Ikeda H, Old LJ, Schreiber RD (2002) The roles of IFN gamma in protection against tumor development and cancer immunoediting. Cytokine Growth Factor Rev, 13, 95-109. https://doi.org/10.1016/S1359-6101(01)00038-7
- Inman BA, Frigola X, Harris KJ et al (2008) Questionable relevance of gamma delta T lymphocytes in renal cell carcinoma. J Immunol, 180, 3578-84. https://doi.org/10.4049/jimmunol.180.5.3578
- Ju MJ, Qiu SJ, Gao Q et al (2009) Combination of peritumoral mast cells and T-regulatory cells predicts prognosis of hepatocellular carcinoma. Cancer Sci, 100, 1267-74. https://doi.org/10.1111/j.1349-7006.2009.01182.x
- Kew MC (2012) Hepatocellular carcinoma in developing countries: Prevention, diagnosis and treatment. World J Hepatol, 4, 99-104. https://doi.org/10.4254/wjh.v4.i3.99
- Kowalczyk D, Skorupski W, Kwias Z et al (1996) Activated gamma/delta T lymphocytes infiltrating renal cell carcinoma. Immunol Lett, 53, 15-8. https://doi.org/10.1016/0165-2478(96)02605-3
- Kuang DM, Peng C, Zhao Q et al (2010) Activated monocytes in peritumoral stroma of hepatocellular carcinoma promote expansion of memory T helper 17 cells. Hepatology, 51, 154-64. https://doi.org/10.1002/hep.23291
- Kuang DM, Zhao Q, Peng C et al (2009) Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1. J Exp Med, 206, 1327-37. https://doi.org/10.1084/jem.20082173
- Li YW, Qiu SJ, Fan J et al (2011) Intratumoral neutrophils: a poor prognostic factor for hepatocellular carcinoma following resection. J Hepatol, 54, 497-505. https://doi.org/10.1016/j.jhep.2010.07.044
- Liao R, Wu H, Yi Y et al (2013) Clinical significance and gene expression study of human hepatic stellate cells in HBV related-hepatocellular carcinoma. J Exp Clin Cancer Res, 32, 22. https://doi.org/10.1186/1756-9966-32-22
- Llovet JM, Di Bisceglie AM, Bruix J et al (2008) Design and endpoints of clinical trials in hepatocellular carcinoma. J Natl Cancer Inst, 100, 698-711. https://doi.org/10.1093/jnci/djn134
- Norris S, Collins C, Doherty DG et al (1998) Resident human hepatic lymphocytes are phenotypically different from circulating lymphocytes. J Hepatol, 28, 84-90.
- Wu H, Chen P, Liao R et al (2012) Overexpression of galectin-1 is associated with poor prognosis in human hepatocellular carcinoma following resection. J Gastroenterol Hepatol, 27, 1312-9. https://doi.org/10.1111/j.1440-1746.2012.07130.x
- Wu X, Zhang JY, Huang A et al (2013) Decreased Vdelta2 gammadelta T cells associated with liver damage by regulation of Th17 response in patients with chronic hepatitis B. J Infect Dis, 208, 1294-304. https://doi.org/10.1093/infdis/jit312
- Yi Y, He HW, Wang JX et al (2013a) The functional impairment of HCC-infiltrating gammadelta T cells, partially mediated by regulatory T cells in a TGFbeta- and IL-10-dependent manner. J Hepatol, 58, 977-83. https://doi.org/10.1016/j.jhep.2012.12.015
- Yi Y, Wu H, Gao Q et al (2013b) Interferon regulatory factor (IRF)-1 and IRF-2 are associated with prognosis and tumor invasion in HCC. Ann Surg Oncol, 20, 267-76. https://doi.org/10.1245/s10434-012-2487-z
- Zhou H, Huang H, Shi J et al (2010) Prognostic value of interleukin 2 and interleukin 15 in peritumoral hepatic tissues for patients with hepatitis B-related hepatocellular carcinoma after curative resection. Gut, 59, 1699-708. https://doi.org/10.1136/gut.2010.218404
Cited by
- Clinical Significance of Joint Detection of Serum VEGF, SIL-2R and HGF in Patients with Primary Hepatocellular Carcinoma before and after Percutaneous Microwave Coagulation Therapy vol.15, pp.11, 2014, https://doi.org/10.7314/APJCP.2014.15.11.4545
- Elevated PIVKA-II is Associated with Early Recurrence and Poor Prognosis in BCLC 0-A Hepatocellular Carcinomas vol.15, pp.16, 2014, https://doi.org/10.7314/APJCP.2014.15.16.6673
- Liver-infiltrating CD11b−CD27− NK subsets account for NK-cell dysfunction in patients with hepatocellular carcinoma and are associated with tumor progression vol.14, pp.10, 2017, https://doi.org/10.1038/cmi.2016.28
- Tumor-infiltrating γδT cells predict prognosis and adjuvant chemotherapeutic benefit in patients with gastric cancer vol.6, pp.11, 2017, https://doi.org/10.1080/2162402X.2017.1353858
- γδ T cells in liver diseases vol.12, pp.3, 2018, https://doi.org/10.1007/s11684-017-0584-x